OMEICOS

OMEICOS is focused on developing therapies that have the potential for a significant impact on cardiovascular, inflammatory and mitochondrial diseases with high unmet need. Our pipeline is based on our proprietary approach to target one of nature's most important cell-protective pathways and industry-leading knowledge of omega-3 fatty acid metabolism and biology.

Also known as: OMEICOS THERAPEUTICS, OMEICOS THERAPEUTICS GMBH, OMEICOS Therapeutics, Inc.

Primary location: Berlin Germany